US2012178780A1PendingUtilityA1
Raf kinase inhibitors
Individually held — no corporate assignee on recordPriority: May 23, 1997Filed: Mar 19, 2012Published: Jul 12, 2012
Est. expiryMay 23, 2017(expired)· nominal 20-yr term from priority
Inventors:Jill WoodHanno WildDaniel RogersJohn Francis LyonsMichael KatzYolanda CaringalRobert DallyWendy LeeRoger SmithCheri Blum
C07D 207/34C07D 409/12C07D 417/12C07D 333/38C07D 307/68A61P 35/00C07D 471/04
60
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Methods of treating tumors mediated by raf kinase, with substituted urea compounds, and such compounds per se.
Claims
exact text as granted — not AI-modified1 . A method for the treatment of cancerous cell growth mediated by raf kinase, comprising administering a compound of the formulae:
2 . A method according to claim 1 , comprising administering a compound of the formulae
3 . A method according to claim 1 , comprising administering a compound of the formula
4 . A method according to claim 1 , comprising administering a compound of formulae
5 . A method according to claim 1 , comprising administering a compound of formulae
6 . A method according to claim 1 , comprising administering a compound of formulae
7 . A method according to claim 1 , comprising administering a compound of formulae
8 . A compound of the formulae
9 . A compound according to claim 8 , of the formulae
10 . A compound according to claim 8 , of the formulae
11 . A compound according to claim 8 , of the formulae
12 . A compound according to claim 8 , of the formulae
13 . A compound according to claim 8 , of the formulae
14 . A compound according to claim 8 , of the formulae
15 . A pharmaceutical composition comprising a compound according to claim 8 and a physiologically acceptable carrier.
16 . A pharmaceutical composition comprising a compound according to claim 14 and a physiologically acceptable carrier.
17 . A pharmaceutical composition comprising a compound according to claim 8 and a physiologically acceptable carrier, in sterile form.Join the waitlist — get patent alerts
Track US2012178780A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.